First-in-class, first-in-human phase I results of targeted agents: Highlights of the 2008 American Society of Clinical Oncology meeting

被引：124

作者：

Molckovsky, Andrea ^{[1
]}

Siu, Lillian L. ^{[1
]}

机构：

[1] Univ Toronto, Princess Margaret Hosp, Div Hematol & Med Oncol, Toronto, ON, Canada

来源：

JOURNAL OF HEMATOLOGY & ONCOLOGY | 2008年 / 1卷 / 1期

关键词：

D O I：

10.1186/1756-8722-1-20

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This review summarizes phase I trial results of 11 drugs presented at the American Society of Clinical Oncology meeting held in Chicago IL from May 30 to June 3rd 2008: BMS-663513, CT-322, CVX-045, GDC-0449, GRN163L, LY2181308, PF-00562271, RAV12, RTA 402, XL765, and the survivin vaccine.

引用

页数：9

共 37 条

[1]

[Anonymous], J CONTRACEPT FERTIL

[2] Hedgehog signalling in skin development and cancer [J].

Athar, Mohammad ;

Tang, Xiuwei ;

Lee, Juliette L. ;

Kopelovich, Levy ;

Kim, Arianna L. .

EXPERIMENTAL DERMATOLOGY, 2006, 15 (09) :667-677

[3] Safety, immunogenicity, and clinical response of a survivin-based peptide vaccine in therapy-resistant advanced cancer: Results from a phase I/II trial [J].

Becker, J. C. ;

Wobser, M. ;

Hofmeister, V. ;

Bauer, B. ;

Broecker, E. B. ;

Straten, P. Thor ;

Andersen, M. H. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

[4] Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies [J].

Bocci, G ;

Man, S ;

Green, SK ;

Francia, G ;

Ebos, JML ;

du Manoir, JM ;

Weinerman, A ;

Emmenegger, U ;

Ma, L ;

Thorpe, P ;

Davidoff, A ;

Huber, J ;

Hicklin, DJ ;

Kerbel, RS .

CANCER RESEARCH, 2004, 64 (18) :6616-6625

[5] Telomere dysfunction and tumour suppression: the senescence connection [J].

Deng, Yibin ;

Chan, Suzanne S. ;

Chang, Sandy .

NATURE REVIEWS CANCER, 2008, 8 (06) :450-458

[6] The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism [J].

Engelman, Jeffrey A. ;

Luo, Ji ;

Cantley, Lewis C. .

NATURE REVIEWS GENETICS, 2006, 7 (08) :606-619

[7] The hedgehog signaling pathway in cancer [J].

Evangelista, Marie ;

Tian, Hua ;

de Sauvage, Frederic J. .

CLINICAL CANCER RESEARCH, 2006, 12 (20) :5924-5928

[8] Phase I trial of intratumoral administration of OBP-301, a novel telomerase-specific oncolytic virus, in patients with advanced solid cancer: Evaluation of biodistribution and immune response [J].

Fujiwara, T. ;

Tanaka, N. ;

Nemunaitis, J. J. ;

Senzer, N. N. ;

Tong, A. ;

Ichimaru, D. ;

Shelby, S. M. ;

Hashimoto, Y. ;

Kawamura, H. ;

Urata, Y. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

[9] Phase I trial with a novel oral NF-κB/STAT3 inhibitor RTA 402 in patients with solid tumors and lymphoid malignancies [J].

Hong, D. S. ;

Kurzrock, R. ;

Supko, J. G. ;

Lawrence, D. P. ;

Wheler, J. J. ;

Meyer, C. J. ;

Mier, J. W. ;

Andreeff, M. ;

Shapiro, G. I. ;

Dezube, B. J. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

[10]

KAREROUNIAN S, 2008, CELL MOL LIFE SCI, V65, P700

← 1 2 3 4 →